ECSS
CRL icon

Eurizon Capital SGR SpA’s Charles River Laboratories CRL Stock Holding History

Eurizon Capital SGR SpA’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Hold
516
– – ﹤0.01% 876
2026
Q1 		$82.8K Hold
516
– – ﹤0.01% 934
2025
Q4 		$104K Buy
+516
New +$93.6K ﹤0.01% 786

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Eurizon Capital SGR SpA's CRL Position: Q2 2026 in Review

Eurizon Capital SGR SpA held its Charles River Laboratories (CRL) position steady in Q2 2026 at 516 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Eurizon Capital SGR SpA first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Eurizon Capital SGR SpA held 516 shares of Charles River Laboratories worth $117K as of Q2 2026.
  • Eurizon Capital SGR SpA left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #876 holding.
  • Eurizon Capital SGR SpA first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.